Cancer and Therapeutics PGDip (DL)
Queen Mary University of London · England · P900081
Cancer and Therapeutics PGDip (DL) is a degree at Queen Mary University of London, England. It covers areas like cancer biology, clinical genetics, health research methods, health promotion, disease prevention, social research methods. The summary below is compiled from public course information — approximate, not official.
Queen Mary University of London
What you'll study in Cancer and Therapeutics PGDip (DL)
Example subjects: Drug Development, Cancer Prevention and Screening, Molecular Diagnostics and Therapeutics, Research Methods, Genomic Approaches to Cancer.
Frequently asked questions
What will I study in Cancer and Therapeutics PGDip (DL)?
Cancer and Therapeutics PGDip (DL) covers areas like cancer-biology, clinical-genetics, quantitative-research-methods, development, therapeutics, genetic-engineering, product-development, biotechnology.
Who offers Cancer and Therapeutics PGDip (DL)?
Cancer and Therapeutics PGDip (DL) is offered by Queen Mary University of London, England.
Considering Cancer and Therapeutics PGDip (DL)?
Peernovo helps students research, choose and thrive at university — across Australia, the US, the UK and Canada — powered by our AI backbone:
- Explore & compare degrees — across universities and countries with honest, specific information.
- "What Can I Be?" career guidance — an AI pathway councillor that maps degrees to careers.
- See who's studying — your degree at your university — find classmates and study groups.
- AI Task Coach — a Socratic study companion that plans your work around your life.
- Honours & Thesis Research Coach — structure and move your research project forward.
- Smart study planner, exam prep and a daily digest — to keep you on track.
Sources: Queen Mary University of London official course page. Information is compiled and summarised — not copied verbatim — and is approximate; always confirm with the original source.
Something not right on this page, or want it changed? Let us know and we'll review it.